Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | OCI INTL (00329): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
Mo | OCI INTL (00329): (1) APPOINTMENT OF NON-EXECUTIVE DIRECTOR; (2) RESIGNATION OF NON-EXECUTIVE DIRECTOR; AND (3) DISSOLUTION OF INVESTMENT COMMITTEE | - | HKEx | ||
24.04. | OCI INTL (00329): NOTICE OF AVAILABILITY TO REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
24.04. | OCI INTL (00329): NOTICE OF AVAILABILITY TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM | - | HKEx | ||
24.04. | OCI INTL (00329): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 21 JUNE 2024, (OR AT ANY ADJOURNMENT THEREOF) | 1 | HKEx | ||
24.04. | OCI INTL (00329): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
24.04. | OCI INTL (00329): (1) PROPOSED RE-ELECTION OF DIRECTORS (2) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES AND (3) NOTICE OF ANNUAL ... | 1 | HKEx | ||
24.04. | OCI INTL (00329): ANNUAL REPORT 2023 | - | HKEx | ||
27.03. | OCI INTL (00329): ANNOUNCEMENT OF FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023 | - | HKEx | ||
15.03. | OCI INTL (00329): DATE OF BOARD MEETING | - | HKEx | ||
17.01. | OCI INTL (00329): LETTER TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND REPLY FORM | 1 | HKEx | ||
17.01. | OCI INTL (00329): LETTER TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND REPLY FORM | - | HKEx | ||
04.01. | OCI INTL (00329): VOLUNTARY ANNOUNCEMENT UPDATE ON DEBT RECOVERY | 2 | HKEx | ||
14.12.23 | OCI INTL (00329): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
14.12.23 | OCI INTL (00329): (1) APPOINTMENTS OF EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER; AND (2) RESIGNATION OF CHIEF EXECUTIVE OFFICER | 1 | HKEx | ||
17.11.23 | OCI INTL (00329): CHANGE OF AUDITOR | 3 | HKEx | ||
08.11.23 | OCI INTL (00329): CHANGE OF COMPANY SECRETARY, AUTHORISED REPRESENTATIVE AND PROCESS AGENT | 1 | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MOBILE-HEALTH NETWORK SOLUTIONS | 22,070 | 0,00 % | Mobile-health Retreats on Opening New Pharmacy | ||
ATRICURE | 22,210 | 0,00 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
FRESENIUS | 28,240 | 0,00 % | DAX-Check LIVE: Daimler Truck, Fresenius, Infineon, Vonovia im Fokus | Der deutsche Leitindex ist gestern mit leichten Verlusten in den Mai gestartet. Am Ende des Tages stand ein Verlust von 0,2 Prozent auf der Kurstafel. Damit schloss er bei 17.896 Punkten und unter der... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 61,69 | 0,00 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
RXSIGHT | 59,63 | 0,00 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
CARL ZEISS MEDITEC | 98,00 | +0,67 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
AGILITI | 10,070 | 0,00 % | DigitalOcean to replace Agiliti in S&P SmallCap Index | ||
PRIVIA HEALTH GROUP | 18,410 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 40,390 | +0,47 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für FMC vor Quartalszahlen von 29 auf 32 Euro angehoben und die Einstufung auf "Underperform" belassen. Nachdem sich der Dialysespezialist... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 51,78 | +1,13 % | Siemens Healthineers: Aktie klettert im DAX - das beflügelt | Die Aktie von Siemens Healthineers sichert sich am Montag einen der Spitzenränge im DAX. Auftrieb verleihen positive News vom Konkurrenten Philips. Dessen Aktie zieht mittlerweile mit einem Plus von... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 11,060 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., May 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
PROGYNY | 32,070 | 0,00 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
GENEDX | 19,490 | 0,00 % | Pre-market Movers: Cyclacel Pharmaceuticals, Marin Software, GeneDx, Sensata Technologies, Lichen China | INDIANAPOLIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.05 A.M. ET).In the Green Cyclacel Pharmaceuticals, Inc. (CYCC) is up... ► Artikel lesen | |
ADAPTHEALTH | 10,350 | 0,00 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook |
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
MIMEDX | 7,500 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen |